Board Change • Aug 12
No independent directors There are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Valuation Update With 7 Day Price Move • Jun 29
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to AU$1.25, the stock trades at a trailing P/E ratio of 27.9x. Average trailing P/E is 36x in the Life Sciences industry globally. Total returns to shareholders of 69% over the past year. Board Change • May 22
No independent directors There are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Board Change • May 20
No independent directors There are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Non-Executive Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Aankondiging • Aug 18
Cryosite Limited, Annual General Meeting, Oct 16, 2025 Cryosite Limited, Annual General Meeting, Oct 16, 2025. Location: at the thomson geer offices, at level 23, rialto south tower, 525 collins street, melbourne vic 3004 Australia Aankondiging • Nov 22
Cryosite Limited Announces Resignation of Michael Austin as Joint Company Secretary Cryosite Limited announced that Mr. Michael Austin has resigned as Joint Company Secretary, effective 22 November 2024. Mr. Hamish George of Bio101 Financial Advisory Pty Ltd. remains as Company Secretary and is responsible for communications with the ASX in relation to Listing Rule matters under ASX Listing Rule 12.6. Aankondiging • Oct 21
Cryosite Limited, Annual General Meeting, Nov 22, 2024 Cryosite Limited, Annual General Meeting, Nov 22, 2024. Location: boardroom, level 2 90 william st, melbourne,vic, 3000., melbourne, Australia Aankondiging • Sep 20
Cryosite Limited Announces Company Secretary Changes Cryosite Limited announced that Hamish George and Michael Austin of Bio101 Financial Advisory Pty Ltd. (Bio101) have been appointed Joint Company Secretaries of the Company. The appointment follows the resignation of Mr. Dray Andrea as Company Secretary, effective 20 September 2024. The Board would like to thank Mr. Andrea for his service in the role of Company Secretary. New Risk • Sep 07
New minor risk - Dividend sustainability The company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.7% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Significant insider selling over the past 3 months (AU$7.5m sold). Market cap is less than US$100m (AU$36.6m market cap, or US$24.4m). Declared Dividend • Aug 22
Final dividend of AU$0.02 announced Shareholders will receive a dividend of AU$0.02. Ex-date: 6th September 2024 Payment date: 10th October 2024 Dividend yield will be 8.6%, which is higher than the industry average of 0.5%. Sustainability & Growth Dividend is well covered by both earnings (46% earnings payout ratio) and cash flows (32% cash payout ratio). The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. Earnings per share has grown by 14% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • Aug 21
Full year 2024 earnings released: EPS: AU$0.038 (vs AU$0.029 in FY 2023) Full year 2024 results: EPS: AU$0.038 (up from AU$0.029 in FY 2023). Revenue: AU$12.6m (up 5.7% from FY 2023). Net income: AU$1.84m (up 31% from FY 2023). Profit margin: 15% (up from 12% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year whereas the company’s share price has increased by 19% per year. Buy Or Sell Opportunity • Jul 31
Now 36% undervalued after recent price drop Over the last 90 days, the stock has fallen 8.8% to AU$0.78. The fair value is estimated to be AU$1.20, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 8.5% over the last 3 years. Earnings per share has grown by 29%. Valuation Update With 7 Day Price Move • Jul 22
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to AU$1.05, the stock trades at a trailing P/E ratio of 32.5x. Average trailing P/E is 34x in the Life Sciences industry globally. Total returns to shareholders of 184% over the past three years. Board Change • Jun 27
No independent directors There are 3 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 3 new directors. No experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). Chairman Mark Kerr is the most experienced director on the board, commencing their role in 2023. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of experienced directors. Aankondiging • Jun 25
Cryosite Limited Announces Retirement of Andrew Kroger from the Board of Directors Cryosite Limited announced that Andrew Kroger has retired from the board of directors (Board) effective from June 25, 2024. Recent Insider Transactions • Apr 27
Non Executive Director recently sold AU$830k worth of stock On the 23rd of April, Andrew Kroger sold around 1m shares on-market at roughly AU$0.83 per share. This transaction amounted to 7.3% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months. Board Change • Apr 19
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Non-Executive Director Andrew Kerr was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Aankondiging • Feb 22
Cryosite Limited Announces Board Changes Cryosite Limited announced the appointment of Mr. Andrew Kerr as a Director of the Company. Mr. John Hogg will step down as Managing Director and continue in his current executive position as CEO of Cryosite. Andrew is an experienced financial services professional in both the Australian and international markets. Andrew is a qualified Certified Practising Accountant (CPA) and a graduate of the Australian Institute of Company Directors (GAICD) course. Through his roles at Bank of America Merrill Lynch and Macquarie Bank, Andrew has obtained strong sustainability and ESG credentials which will greatly complement the Board. Upcoming Dividend • Feb 14
Upcoming dividend of AU$0.05 per share at 2.2% yield Eligible shareholders must have bought the stock before 21 February 2024. Payment date: 29 February 2024. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of Australian dividend payers (6.5%). Higher than average of industry peers (0.5%). Board Change • Feb 01
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman Mark Kerr was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Jan 05
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman Mark Kerr was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Dec 17
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman Mark Kerr was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Aankondiging • Dec 08
Cryosite Limited Announces Director Changes Cryosite Limited announced the appointment of Mr. Mark Kerr, as a new Director and Chairman. Mr. John Hogg, CEO of Cryosite will also join the Board as the Managing Director. The only variation to Mr. Hogg's employment agreement is to reflect his new office with the Company. The company announced the retirement from the Board of Directors of Steven Waller, Nicola Swift and Luis Antonio. The Board thanks the three retiring directors for their outstanding contribution to the Company over a number of years. The retiring directors have contributed substantial hours beyond what was expected to ensure the success of the Company going forward. Aankondiging • Oct 02
Cryosite Limited, Annual General Meeting, Nov 23, 2023 Cryosite Limited, Annual General Meeting, Nov 23, 2023, at 11:01 AUS Eastern Standard Time. Location: The offices of Cryosite, 13A Ferndell St, South Granville New South Wales Australia Aankondiging • Aug 25
Cryosite Limited Announces Dividend for the Twelve Months Ended June 30, 2023, Payable on October 6, 2023 Cryosite Limited announced dividend of AUD 0.01500000 per share for the twelve months ended June 30, 2023. Record date is September 8, 2023. Ex-date is September 7, 2023. Payment date is October 6, 2023. Reported Earnings • Feb 24
First half 2023 earnings released: EPS: AU$0.014 (vs AU$0.016 in 1H 2022) First half 2023 results: EPS: AU$0.014 (down from AU$0.016 in 1H 2022). Revenue: AU$5.72m (down 1.7% from 1H 2022). Net income: AU$678.7k (down 13% from 1H 2022). Profit margin: 12% (down from 13% in 1H 2022). Aankondiging • Jan 20
Cryosite Limited Announces Change of Company Secretary Cryosite Limited announces the resignation of Kim Bradley-Ware and the appointment of Dray Andrea as Company Secretary, both effective January 18, 2023. Recent Insider Transactions • Jan 19
Insider recently bought AU$481k worth of stock On the 13th of January, Mark Kerr bought around 650k shares on-market at roughly AU$0.74 per share. This transaction amounted to 39% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger purchase worth AU$582k. Insiders have collectively bought AU$2.6m more in shares than they have sold in the last 12 months. Recent Insider Transactions • Dec 24
Insider recently bought AU$582k worth of stock On the 19th of December, Mark Kerr bought around 885k shares on-market at roughly AU$0.66 per share. This transaction amounted to 79% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$2.1m more in shares than they have sold in the last 12 months. Recent Insider Transactions • Oct 14
Insider recently bought AU$447k worth of stock On the 11th of October, Mark Kerr bought around 600k shares on-market at roughly AU$0.74 per share. This transaction amounted to 63% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$1.6m more in shares than they have sold in the last 12 months. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Recent Insider Transactions • Mar 03
Non Executive Director recently bought AU$321k worth of stock On the 28th of February, Andrew Kroger bought around 716k shares on-market at roughly AU$0.45 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$931k more in shares than they have sold in the last 12 months. Reported Earnings • Feb 26
First half 2022 earnings: Revenues and EPS in line with analyst expectations First half 2022 results: EPS: AU$0.016 (up from AU$0.006 in 1H 2021). Revenue: AU$5.82m (up 19% from 1H 2021). Net income: AU$782.4k (up 175% from 1H 2021). Profit margin: 13% (up from 5.8% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Board Change • Feb 26
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Jan 05
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Dec 11
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Oct 05
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. 1 independent director (2 non-independent directors). Independent Non-Executive Director Nicola Swift was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Aug 27
Full year 2021 earnings released: EPS AU$0.014 (vs AU$0.032 in FY 2020) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2021 results: Revenue: AU$10.1m (up 12% from FY 2020). Net income: AU$652.6k (down 56% from FY 2020). Profit margin: 6.5% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Recent Insider Transactions • Jun 11
Non Executive Director recently bought AU$170k worth of stock On the 8th of June, Andrew Kroger bought around 473k shares on-market at roughly AU$0.36 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought AU$173k more in shares than they have sold in the last 12 months.